Blog

Top Posts

Why We’re Pledging #NoGoingBack for Clinical Trials

Posted

The #NoGoingBack pledge is a statement from organisations across the world to continue forging forward. It’s a united front, and shows the importance of clinical leaders coming together to continue the momentum we’ve created in improving clinical trial conduct around the world.

World Diabetes Day 2020: Spotlight On Patient Experience

Posted

Saturday 14th November 2020 is World Diabetes Day, so we wanted to do our part in raising awareness and explore the experience of Diabetes from the perspective of patients and their families.

mdgroup Joins The Beryl Institute Community

Posted

We recently joined The Beryl Institute community as an organisational member. Organisational members create market distinction by supporting a culture where staff at all levels have access to patient experience resources and show their understanding that patient experience is an integration of quality, safety and service.

The Complete Guide to Improving Patient Retention in Clinical Trials

Posted

In this comprehensive guide to improving patient retention in clinical trials, we explore the impact of a high level of patient focus and support on recruitment and retention rates. We’ll also offer our expert insight into key ways to prioritise patients at every stage of the clinical journey.

Why Decentralisation Is The Future Of Clinical Trials

Posted

Decentralisation of clinical trials has been a growing topic of discussion and development over the last few years, enabled further by the advancement of available technologies. Here, we explore what we mean when we talk about decentralised trials and discuss why the clinical research industry has been reluctant to pursue this route. We illuminate the […]

COVID-19

Clinical Trial Continuity During The Ongoing COVID-19 Pandemic

Posted

The clinical trial landscape has changed dramatically since the outbreak of COVID-19. For the clinical research industry, these past few months have been anything but business as usual. However, it hasn’t meant clinical trials can’t continue, and many in the industry have been working together to find a ‘new normal’.

Meeting Services

How To Get The Most Out Of Virtual Meetings

Posted

The outbreak of COVID-19 caused most businesses to change how they operate, with travel restrictions and remote work arrangements becoming commonplace around the world. It’s time to bring virtual meetings into focus.

Patient Centricity

Why Do Patients Drop Out Of Clinical Trials?

Posted

In this article, we look at how to create patient-centric clinical trials that reduce the patient dropout rate from 30% to 0%.

COVID-19

COVID-19 Pandemic: What Lessons Can We Learn to Put Patients First in Clinical Trial Design

Posted

The COVID-19 pandemic has forced quick thinking and adaptation in clinical trials to ensure patient safety and, where possible, continue research and preserve study integrity. Changes have impacted protocols, use of technologies, data collection, and how patients are participating in trials. On June 11, we hosted the first of a series of mdWebinars to facilitate […]